With an ever-increasing emphasis on minimising drug candidate attrition, scientists are focusing on target safety at earlier points in the research process. In this exclusive interview, Drug Target Review spoke with Dr Gordon Baxter, Chief Scientific Officer of Instem, to learn how target safety assessments can enable researchers to quickly identify and assess unintended adverse consequences of potential treatments before expensive investment is made.

Watch this on-demand webinar to learn how the two assays developed by Eurofins provide a more comprehensive pre-clinical model for cardiac liability assessment.

The exciting new study demonstrates how the technology could be used to improve animal welfare in scientific research and agriculture.

Scientists used a new screen to identify FAM72A as a cause of mutagenesis that affects antibody development in COVID-19 and cancer.

GlaxoSmithKline (GSK) and the University of Oxford will collaborate to investigate diseases using technologies such as functional genomics and machine learning.